Search Results - "pancreatic cancer"

1

Targeted Polymeric Nanoparticles: Radiolabelling with GA-67 and in vivo evaluation in a mouse model of pancreatic adenocarcinoma using single photon emission computerized tomograph...

by Gil-Iceta, L. (Larraitz), Llop-Roig, J. (Jordi), Peñuelas-Sanchez, I. (Ivan)
Published 2017
“…Within the frame of the EU-funded project SaveMe , NP-based theranostic agents for the early detection and treatment of Pancreatic Cancer (PaCa, the fourth deadliest cancer type), have been developed. …”

Get full text

info:eu-repo/semantics/doctoralThesis
2

Therapeutic drug monitoring of neoadjuvant mFOLFIRINOX in resected pancreatic ductal adenocarcinoma

by Vilalta, A. (Anna), Aldaz, A. (Azucena), Sala-Elarre, P. (Pablo), Urrizola-Martínez, A. (Amaia), Chopitea, A. (Ana), Arbea-Moreno, L. (Leire), Rotellar, F. (Fernando), Pardo, F. (Fernando), Marti-Cruchaga, P. (Pablo), Zozaya-Larequi, G. (Gabriel), Subtil, J.C. (José Carlos), Rodríguez-Rodríguez, J. (Javier), Ponz-Sarvise, M. (Mariano)
Published 2023
“…Pharmacokinetic-guided (PKG) dosing has demonstrated beneficial effects in other tumors, but scarce data is available in pancreatic cancer. Methods: Forty-six patients with resected PDAC after mFOLFIRINOX neoadjuvant approach and included in an institutional protocol for anticancer drug monitoring were retrospectively analyzed. 5-Fluorouracil (5-FU) dosage was adjusted throughout neoadjuvant treatment according to pharmacokinetic parameters and Irinotecan (CPT-11) pharmacokinetic variables were retrospectively estimated. …”

Get full text

info:eu-repo/semantics/article

Refine Results